Mobile Site ›

Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

An Update


Receive notification when new Hot Topics are published:

AGID: Antibody Evaluation

Slide 8

April 2012

In that context, the autoimmune gastrointestinal dysmotility antibody evaluation can aid the diagnosis of both idiopathic autoimmune and paraneoplastic disorders and, as mentioned, multiple antibodies are commonly found coexisting together and the specific neoplasm may be predictable by the antibody profile. For example, ANNA-1 antibody with an N-type calcium channel antibody is predictive of small cell carcinoma.

AGID: Antibody Evaluation


Jump to section: